The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index; 57 of the 310 sources its claims cite were checked for support.
Bone remodeling: an operational process ensuring survival and bone mechanical competence
Open accessAbstract
Bone remodeling replaces old and damaged bone with new bone through a sequence of cellular events occurring on the same surface without any change in bone shape. It was initially thought that the basic multicellular unit (BMU) responsible for bone remodeling consists of osteoclasts and osteoblasts functioning through a hierarchical sequence of events organized into distinct stages. However, recent discoveries have indicated that all bone cells participate in BMU formation by interacting both simultaneously and at different differentiation stages with their progenitors, other cells, and bone matrix constituents. Therefore, bone remodeling is currently considered a physiological outcome of continuous cellular operational processes optimized to confer a survival advantage. Bone remodeling defines the primary activities that BMUs need to perform to renew successfully bone structural units. Hence, this review summarizes the current understanding of bone remodeling and future research directions with the aim of providing a clinically relevant biological background with which to identify targets for therapeutic strategies in osteoporosis.
Overview
CoChat Summary
TL;DR
This review reframes bone remodeling as a continuous, integrated operational process executed by basic multicellular units (BMUs), rather than a strict sequence of discrete stages, with osteocytes, osteoclasts, osteoblasts, lining/canopy cells, reversal cells, and osteomorphs all contributing. It synthesizes mechanotransduction, RANKL/RANK/OPG signaling, coupling factors, and intermediate cell phenotypes to identify therapeutic targets in osteoporosis.
Key findings
- Bone remodeling is a continuous flow of connected cellular events, not discrete stages; the BMU includes all bone cells at all differentiation stages, and focal coupling is asynchronous, producing a transient “virtual space” of bone loss. The BMU endures longer (9 months) than the lifespan of each single component.
- Osteocytes are master coordinators: they represent more than 90% of adult bone cells, with an estimated 19,000–28,500 cells per mm³ (~42 billion cells) and 23 trillion connections; Frost estimated an osteocyte lifespan of ~25 years, and 9.1 million osteocytes are replaced daily. They sense fluid flow shear stress via collagen hillocks, integrins, primary cilia, connexin43, and Piezo1, and regulate RANKL/OPG/SOST.
- Osteoclasts can be “anabolic” independent of resorption: in osteoclast-rich osteopetrosis and with odanacatib, bone formation is maintained or enhanced despite impaired resorption. Osteoclast-derived factors (CT-1, S1P, Wnt10B, BMP6, CTHRC1, C3a, LIF, SLIT3, DPP4) and extracellular vesicles (25–120 nm) carrying RANK can promote osteogenesis via reverse signaling.
- Intermediate phenotypes tune coupling: active osteoblasts have an average lifespan of 3 months; 60%–80% die by apoptosis and 5%–20% become osteocytes. Reversal cells colonize eroded surfaces covering 80% of them, and osteomorph recycling helps explain denosumab discontinuation rebound.
Methods
- Narrative review: the authors describe, update, and reexamine current evidence and biological plausibility for bone remodeling, explicitly presenting it as a continuous flow rather than staged process.
- No systematic search strategy, databases, inclusion/exclusion criteria, or primary data collection are reported; the synthesis draws on cited animal models, human biopsy/imaging studies, and clinical trials.
- Main analysis is conceptual integration of cellular and molecular mechanisms, including BMU structure, osteocyte mechanosensing, osteoclast–osteoblast coupling, and therapeutic implications.
Limitations
- The paper states several unresolved issues: the exact in vivo form and localization of osteocyte RANKL; how the bone remodeling compartment forms; whether osteoclast-derived coupling factors act similarly in humans; the mechanism controlling apoptotic body delivery within each BMU; the role of 1,25(OH)₂D₃ in osteocyte metabolism; how osteocytes sense phosphate; and the efficiency of perilacunar remodeling in calcium homeostasis.
- Evident from the text: as a narrative review, it lacks systematic search and quality appraisal, relies on heterogeneous preclinical and clinical evidence, and includes speculative or hypothetical mechanisms (e.g., “might,” “hypothesized”) without new primary data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
42 Valid · 4 Not valid · 201 Not checked · 72 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Recently, Sato et al.20,44 showed that FFSS induces the disruption of the FAK-integrin complex, thereby inhibiting histone deacetylase 4/5 (HDAC4/5), a negative regulator of SOST expression in osteocytes45 modulated by parathyroid hormone (PTH) treatment.46”
§ Bone remodeling: an operational process ensuring survival and bone mechanical competence > Osteocytes: tuning, initiation and termination of bone remodeling
What the sources say
- Not checked yetcites [20] Chung, D. J. et al. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J. Cell Sci. 119, 4187–4198 (2006). source
- Disputedcites [44] Sato, T. et al. A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction. Nat. Commun. 11, 3282 (2020). sourceExperimental — accuracy not yet measured
The Introduction reports that FFSS inhibits FAK activity but triggers HDAC4/5 nuclear translocation; it does not say FFSS inhibits HDAC4/5. The Results section on constitutive integrin signaling proposes that FFSS may disrupt cell–matrix interactions, rather than demonstrating disruption of a FAK–integrin complex. The paper therefore describes the opposite HDAC4/5 response from the one attributed to it. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [45] Wein, M. N. et al. HDAC5 controls MEF2C-driven sclerostin expression in osteocytes. J. Bone Miner. Res. 30, 400–411 (2015). sourceExperimental — accuracy not yet measured
The Discussion identifies HDAC5 as a negative regulator of SOST expression in osteocytes. The Results, however, show increased sclerostin after HDAC5 knockdown but not HDAC4 knockdown, so this source does not establish the claim for HDAC4/5 together. The FFSS–FAK mechanism and PTH treatment are attached to other citations in the citing sentence. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Throughout aging, a large and linear reduction in dendrite number and cell body density directly related to the deterioration of cortical parameters has been observed.18”
§ Bone remodeling: an operational process ensuring survival and bone mechanical competence > Osteocytes: tuning, initiation and termination of bone remodeling
What the sources say
- Partly supportedcites [18] Tiede-Lewis, L. M. et al. Degeneration of the osteocyte network in the C57BL/6 mouse model of aging. Aging 9, 2190–2208 (2017). sourceExperimental — accuracy not yet measured
The Results section (page unavailable) reports a large age-related reduction in dendrite number and osteocyte density in mice, but a linear decline only for dendrite number in females aged 5–22 months. Osteocyte density peaked at 12 months before declining. Dendrite number correlated with cortical thickness and perimeter; the cited passages do not establish the same relationship for cell-body density or a direct causal link to cortical deterioration. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The deformation of the osteocyte cytoskeleton elicits Ca2+ influx signaling via the activation of TRPV4.34”
§ Bone remodeling: an operational process ensuring survival and bone mechanical competence > Osteocytes: tuning, initiation and termination of bone remodeling
What the sources say
- Supportedcites [34] Lyons, J. S. et al. Microtubules tune mechanotransduction through NOX2 and TRPV4 to decrease sclerostin abundance in osteocytes. Sci. Signal. 10, eaan5748 (2017). source
The Discussion (page not provided) describes fluid shear stress triggering microtubule-dependent NOX2 activation, followed by ROS activation of TRPV4-dependent Ca2+ influx in osteocytes. The Results section on Ocy454 cells (page not provided) also reports that TRPV4 inhibition reduced the fluid-shear-induced Ca2+ response. The claim is a broad paraphrase of this mechanotransduction pathway, not a claim that cytoskeletal deformation activates TRPV4 directly. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Indeed, ATP from apoptotic osteocytes might bind P2Y2 receptors expressed on bystander osteocytes, which in turn might activate RANKL production and release67 (Fig. 2).”
§ Bone remodeling: an operational process ensuring survival and bone mechanical competence > Osteocytes: tuning, initiation and termination of bone remodeling
What the sources say
- Partly supportedcites [67] Cheung, W. Y. et al. Pannexin-1 and P2X7-receptor are required for apoptotic osteocytes in fatigued bone to trigger RANKL production in neighboring bystander osteocytes. J. Bone Miner. Res. 31, 890–899 (2016). sourceExperimental — accuracy not yet measured
The Discussion of Cheung et al. (2016) does raise exactly this kind of alternative in the context of apoptotic-osteocyte-to-bystender-osteocyte ATP signalling: 'we cannot exclude additional mechanisms, e.g. involving same-cell (autocrine) ATP signaling or signaling via other receptors such as P2Y, which are expressed on osteoblasts(67) and were reported to mediate upregulation of RANKL(68).' So the general idea (ATP from dying osteocytes acting on P2Y receptors to drive RANKL) is present as the paper's own hedged speculation. However, the specific subtype P2Y2 is nowhere in our copy (searched 'P2Y2 nucleotide receptor'; the only P2Y subtypes named are P2Y1 in ref 23 and P2Y6 in ref 25, and the P2Y expression statement is attributed to osteoblasts, not bystander osteocytes, crediting Orriss et al. 2011 and Gallagher 2004), and RANKL 'release' is not addressed — the paper's own tested mechanism is Panx1/P2X7R, with P2Y mentioned only as an unexcluded possibility. (LLM, conf=0.75)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Nevertheless, OPG released by mature osteoblasts and/or osteocytes may constitute the termination signal of the resorption phase in the remodeling cycle.77”
§ Bone remodeling: an operational process ensuring survival and bone mechanical competence > Osteocytes: tuning, initiation and termination of bone remodeling
What the sources say
- Partly supportedcites [77] Cawley, K. M. et al. Local production of osteoprotegerin by osteoblasts suppresses bone resorption. Cell Rep. 32, 108052 (2020). sourceExperimental — accuracy not yet measured
The Discussion proposes that OPG produced by mature osteoblasts may signal the end of the resorption phase. It does not extend that proposed termination signal to osteocytes; the Discussion instead identifies mature osteoblasts as the essential OPG source suppressing cancellous-bone resorption. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
160 more claims · 24 with their cited sources checked
Create a free account to see all 319 claims and to verify the 253 references still open.
- It may state two separate claims as one. 129
- Probably not a substantial claim. 33
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Bone remodeling: an operational process ensuring survival and bone mechanical competence > Osteocytes: tuning, initiation and termination of bone remodeling
“FFSS induces the disruption of the FAK-integrin complex, thereby inhibiting histone deacetylase 4/5 (HDAC4/5), a negative regulator of SOST expression in osteocytes45”
§ Bone remodeling: an operational process ensuring survival and bone mechanical competence > Osteocytes: tuning, initiation and termination of bone remodeling
“Mechanical signals activate the anabolic Wnt pathway in bone through the suppression of the Wnt receptor antagonist sclerostin (SOST).”
Citations
Cites
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
The Feynman Lectures on Physics
Feynman, R. P., Leighton, R. B., Sands, M., & Treiman, S. B. (1964) · Physics Today · doi:10.1063/1.3051743 · Cited by 2,939
Liao, J., Wei, Q., Zou, Y., Fan, J., Song, D., Cui, J., Zhang, W., Zhu, Y., Ma, C., Hu, X., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471945 · Cited by 2,742
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Dempster, D. W., Compston, J. E., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., Recker, R. R., & Parfitt, A. M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1805 · Cited by 2,543
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
Kusumbe, A. P., Ramasamy, S. K., & Adams, R. H. (2014) · Nature · doi:10.1038/nature13145 · Cited by 2,155
Research works printed but not linked: 3
- Bonewald, L. F. & Marcus, D. F. R. In Osteoporosis 3rd edn (eds Nelson, D. & Rosen, C.) 170–189 (Elsevier, 2008).
- Baron, R., Vignery, A. & Van Tran, P. The significance of lacunar erosion without osteoclasts: studies on the reversal phase of the remodeling sequence. Metab. Bone Dis. Relat. Res. 2, 35–40 (1980).
- Marotti, G., Ferretti, M., Palumbo, C. & Benincasa, M. Static anddynamic bone formation and the mechanism of collagen fiberorientation. Bone 25, 156 (1999).
Cited by
Recent Advances in 3D Printing of Smart Scaffolds for Bone Tissue Engineering and Regeneration
Yuan, X., Zhu, W., Yang, Z., He, N., Chen, F., Han, X., & Zhou, K. (2024) · Advanced Materials · doi:10.1002/adma.202403641 · Cited by 339
Osteocyte mechanotransduction in orthodontic tooth movement
Seddiqi, H., Klein-Nulend, J., & Jin, J. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00826-2 · Cited by 46
Bone analysis using an aggregation‐induced emission‐active iridium complex
Zhang, X., Liu, X., Yu, H., Shen, S., Zhi, J., Gao, Z., Xin, J., Song, J., Shao, L., Meng, C., et al. (2023) · Aggregate · doi:10.1002/agt2.381 · Cited by 26
Metadata
- Authors
- Bolamperti, S., Villa, I., & Rubinacci, A.
- Affiliations
- IRCCS Ospedale San Raffaele (IT)
- Corresponding author
- Rubinacci, Alessandro
- Venue
- Bone Research
- Published
- 2022-07-18
- Volume
- 10
- Issue
- 1
- Pages
- 48-48
- ISSN
- 2095-4700 (ISSN-L)
- 2095-6231
- PMC
- PMC9293977
- OpenAlex
- W4285729461
- Cited by
- 482
- References
- 291
- Citations by year
- 2026: 137 · 2025: 161 · 2024: 112 · 2023: 64 · 2022: 8
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Bone Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Keywords
- bone remodeling, basic multicellular unit, osteoclasts, osteoblasts, bone cells, bone matrix, osteoporosis, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone remodeling: an operational process ensuring survival and bone mechanical competence. https://app.cochat.ai/papers/10.1038/s41413-022-00219-8
- The paper
- Bolamperti, S., Villa, I., & Rubinacci, A. (2022). Bone remodeling: an operational process ensuring survival and bone mechanical competence. Bone Research. https://doi.org/10.1038/s41413-022-00219-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.